The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV
Abstract
We studied the frequency, severity, and clinical correlations of cerebral amyloid angiopathy (CAA) in 117 CERAD subjects with autopsy-confirmed AD. Eighty-three percent showed at least a mild degree of amyloid angiopathy. Thirty of 117 brains (25.6%) showed moderate to severe CAA affecting the cerebral vessels in one or more cortical regions. These brains also showed a significantly higher frequency of hemorrhages or ischemic lesions than those of subjects with little or no amyloid angiopathy (43.3% versus 23.0%; odds ratio = 2.6, 95% CI = 1.1 to 6.2) High CAA scores also correlated with the presence of cerebral arteriosclerosis and with older age at onset of dementia. Our findings suggest that factors contributing to non-AD-related vascular pathology (e.g., atherosclerosis) may play a role in amyloid deposition in cerebral vessels in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is strong experimental evidence that the APOE isoforms are major determinants of the amount and quality of amyloid-β peptide (Aβ) and amyloid burden in the brain that develops during aging.15–17”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [16]
In the citing paper
“Atherosclerosis has been associated with AD and cerebral angiopathy in humans [43], [44], and recent findings indicate that vascular risk factors and neurovascular dysfunction play integral roles in the pathogenesis of AD [45].”
From ApoB100/LDLR-/- Hypercholesterolaemic Mice as a Model for Mild Cognitive Impairment and Neuronal Damage (2011) · cites this paper as [44]
In the citing paper
“Neuropathological examination of patient brains harboring APP duplications show abundant plaque and tangle pathology as well cerebral amyloid angiopathy (CAA)”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [249]
Citations
Cites
Arteriovenous malformations of the brain: natural history in unoperated patients.
Crawford, P. M., West, C. R., Chadwick, D. W., & Shaw, M. D. M. (1986) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.1.1 · Cited by 814
Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study
Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662
Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases
Joachim, C. L., Morris, J. H., & Selkoe, D. J. (1988) · Annals of Neurology · doi:10.1002/ana.410240110 · Cited by 362
Self-citationGasset, M., Baldwin, M. A., Fletterick, R. J., & Prusiner, S. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.1 · Cited by 307
Pre‐and Postmortem Influences on Brain RNA
BARTON, A. J. L., Pearson, R. C. A., Najlerahim, A., & Harrison, P. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03532.x · Cited by 269
Clinicopathologic Studies of Primary Cerebral Amyloid Angiopathy
Okazaki, H., Reagan, T. J., & Campbell, R. J. (1979) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18993-3 · Cited by 259
Olichney, J. M., Hansen, L., Hofstetter, C., Grundman, M., Katzman, R., & Thal, L. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310076019 · Cited by 251
Self-citationEvaluation of thermography in the diagnosis of selected entrapment neuropathies
So, Y. T., Olney, R. K., & Aminoff, M. J. (1989) · Neurology · doi:10.1212/wnl.39.1.1 · Cited by 171
Roher, A. E., Palmer, K. C., Yurewicz, E. C., Ball, M. J., & Greenberg, B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09834.x · Cited by 144
Immunocytochemical localization of estrogen-induced progestin receptors in guinea pig brain
Blaustein, J. D., King, J. C., Toft, D. O., & Turcotte, J. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90664-6 · Cited by 144
Research works printed but not linked: 15
- Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983;14:924-928.
- Glenner GG, Henry JH, Fujihara S. Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol 1981;1:120-129.
- Armstrong RA, Myers D, Smith CU. The ratio of diffuse to mature beta/A4 deposits in Alzheimer's disease varies in cases with and without congophilic angiopathy. Dementia 1993;4:251-255.
- Lopez O, Claassen D, Boller F. Alzheimer's disease, cerebral amyloid angiopathy, and dementia of acute onset. Aging 1991;3:171-175.
- Aronson MK, Ooi WL, Geva DL, et al. Dementia. Age-dependent incidence, prevalence, and mortality in the old old. Arch Intern Med 1991;151:989-992.
- Gilbert JJ, Vinters HV. Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke 1983;14:915-923.
- Mandybur TI. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol 1986;45:79-90.
- Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finkelstein SP. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993;43:2073-2079.
- Hendriks L, Van DC, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nature Genet 1992;1:218-221.
- Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
- Ishihara T, Takahashi M, Yokota T, et al. The significance of cerebral vascular amyloid in the aetiology of superficial (lobar) cerebral haemorrhage and its incidence in the elderly population. J Pathol 1991;165:229-234.
- Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol 1987;234:371-376.
- Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y. High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 1994;145:452-460.
- Wisniewski HM, Wegiel J. Beta-amyloid formation by myocytes of amyloid vessels. Acta Neuropathol 1994;87:233-241.
- Kawai M, Kalaria RN, Cras P, et al. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer's disease. Brain Res 1993;63:142-146.
Cited by
Sorted by citations
Items 301–400 of 560
Tanskanen, M., Kiuru‐Enari, S., Tienari, P. J., Polvikoski, T. M., Verkkoniemi, A., Rastas, S., Sulkava, R. O., & Paetau, A. E. (2006) · Amyloid · doi:10.1080/13506120600876757 · Cited by 33
Abu‐Rumeileh, S., Capellari, S., & Parchi, P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171181 · Cited by 35
Endothelial‐derived plasma exosome proteins in Alzheimer’s disease angiopathy
Abner, E. L., Elahi, F. M., Jicha, G. A., Mustapić, M., Al‐Janabi, O. M., Kramer, J. H., Kapogiannis, D., & Goetzl, E. J. (2020) · The FASEB Journal · doi:10.1096/fj.202000034r · Cited by 34
Thonberg, H., Fallström, M., Björkström, J., Schoumans, J., Nennesmo, I., & Graff, C. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-476 · Cited by 35
Zha, Z., Jin, S., Choi, S., Wu, Z., Plöessl, K., Smith, M., & Kung, H. F. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00127 · Cited by 32
Impact of spontaneous intracerebral hemorrhage on cognitive functioning: An update
Planton, M., Raposo, N., Danet, L., Albucher, J., Péran, P., & Pariente, J. (2017) · Revue Neurologique · doi:10.1016/j.neurol.2017.06.010 · Cited by 36
Zhu, N., Wei, M., Yuan, L., He, X., Chen, C., Ji, A., & Zhang, G. (2022) · Aging · doi:10.18632/aging.204029 · Cited by 34
Cerebral amyloid angiopathy and Alzheimer’s disease
de Courten‐Myers, G. M. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.004 · Cited by 32
Ramírez, C., Sierra, S., Tercero, I., Vázquez, J. A., Pineda, A., Manrique, T., & Burgos, J. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022712 · Cited by 31
Cerebral Microbleeds as a Biomarker in Alzheimer’S Disease? A Review in The Field
Shams, S., & Wahlund, L.-O. (2016) · Biomarkers in Medicine · doi:10.2217/bmm.15.101 · Cited by 32
Molecular Pathogenesis and Interventional Strategies for Alzheimer’s Disease: Promises and Pitfalls
Bhute, S., Sarmah, D., Datta, A., Rane, P., Shard, A., Goswami, A., Borah, A., Kalia, K., Dave, K. R., & Bhattacharya, P. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00104 · Cited by 32
(ADNI), T. A. D. N. I., Valant, V., Keenan, B. T., Anderson, C. D., Shulman, J. M., Devan, W. J., Ayres, A. M., Schwab, K. M., Goldstein, J. N., Viswanathan, A., et al. (2012) · Translational Stroke Research · doi:10.1007/s12975-012-0161-1 · Cited by 30
Reddy, J. S., Allen, M., Ho, C. C. G., Oatman, S. R., İş, Ö., Quicksall, Z., Wang, X., Jin, J., Patel, T., Carnwath, T., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01199-2 · Cited by 28
Alzheimer's Disease and Vascular Dementia: Some Points of Confluence
Agüero‐Torres, H., & Winblad, B. G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06412.x · Cited by 31
Prevention of age-associated dementia
Mohajeri, M. H., & Leuba, G. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.06.014 · Cited by 31
Cerebrovascular medin is associated with Alzheimer's disease and vascular dementia
Migrino, R. Q., Karamanova, N., Truran, S., Serrano, G. E., Davies, H. A., Madine, J., & Beach, T. G. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12072 · Cited by 28
Peters, E. C., Gee, M. T., Pawlowski, L. N., Kath, A. M., Polk, F. D., Vance, C. J., Sacoman, J. L., & Pires, P. W. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211039592 · Cited by 31
Princz-Kranz, F. L., Mueggler, T., Knobloch, M., Nitsch, R. M., & Rudin, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.002 · Cited by 28
High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease
Soontornniyomkij, V., Choi, C., Pomakian, J., & Vinters, H. V. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.04.011 · Cited by 28
Planton, M., Saint‐Aubert, L., Raposo, N., Payoux, P., Salabert, A., Albucher, J., Olivot, J., Péran, P., & Pariente, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190625 · Cited by 26
Inoue, Y., Nakajima, M., Uetani, H., Hirai, T., Ueda, M., Kitajima, M., Utsunomiya, D., Watanabe, M. J. L., Hashimoto, M., Ikeda, M., et al. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4496 · Cited by 29
Prospects of Saffron and its Derivatives in Alzheimer’s Disease
Zandi, N., Pazoki, B., Roudsari, N. M., Lashgari, N., Jamshidi, V., Momtaz, S., Abdolghaffari, A. H., & Akhondzadeh, S. (2021) · Archives of Iranian Medicine · doi:10.34172/aim.2021.35 · Cited by 25
Willumsen, N., Poole, T., Nicholas, J. M., Fox, N. C., Ryan, N. S., & Lashley, T. (2021) · Brain Pathology · doi:10.1111/bpa.13009 · Cited by 25
Alzheimer’s Silent Partner: Cerebral Amyloid Angiopathy
Cupino, T. L., & Zabel, M. K. (2013) · Translational Stroke Research · doi:10.1007/s12975-013-0309-7 · Cited by 27
Are vascular factors involved in Alzheimer’s disease? Facts and theories
Iorio, A. D., Zito, M., Lupinetti, M. C., & Abate, G. (1999) · Aging Clinical and Experimental Research · doi:10.1007/bf03339811 · Cited by 25
The presence of cerebral microbleeds is associated with cognitive impairment in Parkinson's disease
Daida, K., Tanaka, R., Yamashiro, K., Ogawa, T., Oyama, G., Nishioka, K., Shimo, Y., Umemura, A., & Hattori, N. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.08.009 · Cited by 24
N-terminally truncated Aβ4-x proteoforms and their relevance for Alzheimer’s pathophysiology
Rostagno, A. A., Cabrera, E., Lashley, T., & Ghiso, J. A. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00303-3 · Cited by 23
Neuropathologic Features and Grading of Alzheimer-Related and Sporadic CAA
Vinters, H. V., & Vonsattel, J. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_8 · Cited by 24
Illuminating amyloid fibrils: Fluorescence-based single-molecule approaches
Rice, L. J., Ecroyd, H. W., & van Oijen, A. M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.017 · Cited by 25
Mendel, T. A., Bertrand, E., Szpak, G. M., Stępień, T., & Wierzba‐Bobrowicz, T. (2010) · PubMed · Cited by 23
Bosentan preserves endothelial function in mice overexpressing APP
Elesber, A. A., Bonetti, P. O., Woodrum, J. E., Zhu, X.-Y., Lerman, L. O., Younkin, S. G., & Lerman, A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.012 · Cited by 23
Diffuse white matter loss in a transgenic rat model of cerebral amyloid angiopathy
Lee, H., Xu, F., Liu, X., Koundal, S., Zhu, X. A., Davis, J., Yanez, D., Schrader, J. M., Stanisavljevic, A., Rothman, D. L., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20944226 · Cited by 22
Cerebral Microbleeds in Fragile X–Associated Tremor/Ataxia Syndrome
Salcedo‐Arellano, M. J., Wang, J. Y., McLennan, Y. A., Doan, M., Cabal‐Herrera, A. M., Jimenez, S., Wolf‐Ochoa, M., Sanchez, D., Juárez, P., Tassone, F., et al. (2021) · Movement Disorders · doi:10.1002/mds.28559 · Cited by 22
Vascular Dysfunction Is Central to Alzheimer’s Disease Pathogenesis in APOE e4 Carriers
McCorkindale, A. N., Mundell, H. D., Guennewig, B., & Sutherland, G. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137106 · Cited by 23
The clinical importance of suspected non-Alzheimer disease pathophysiology
Vos, S. J. B., Delvenne, A., Jack, C. R., Thal, D. R., & Visser, P. J. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00962-y · Cited by 23
Does a Positive Pittsburgh Compound B Scan in a Patient With Dementia Equal Alzheimer Disease?
Ducharme, S., Guiot, M., Nikelski, J., & Chertkow, H. M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.420 · Cited by 22
Solé, M., Miñano-Molina, A. J., & Unzeta, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.030 · Cited by 22
Pontes‐Neto, O. M., Auriel, E., & Greenberg, S. M. (2012) · European Neurological Review · doi:10.17925/enr.2012.07.02.134 · Cited by 22
Niwa, A., Ii, Y., Shindo, A., Matsuo, K., Ishikawa, H., Taniguchi, A., Takase, S., Maeda, M., Sakuma, H., Akatsu, H., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161242 · Cited by 21
Aniwattanapong, D., Tangwongchai, S., Supasitthumrong, T., Hemrunroj, S., Tunvirachaisakul, C., Tawankanjanachot, I., Chuchuen, P., Snabboon, T., Carvalho, A. F., & Maes, M. H. J. (2018) · Aging & Mental Health · doi:10.1080/13607863.2018.1501668 · Cited by 21
The significance of small cerebral bleeds in neurodegenerative dementia syndromes.
Reuck, J. L. D. (2012) · Europe PMC (PubMed Central) · Cited by 20
Reith, F. H., Mormino, E. C., & Zaharchuk, G. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12212 · Cited by 19
Montero, M. V., Pastor, Á. G., Iglesias-Mohedano, A. M., Antonio, E. E., Salgado-Cámara, P., García‐Domínguez, J. M., Vázquez-Alén, P., Díaz‐Otero, F., Bullido, Y. F., & Gil-Núñez, A. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116452 · Cited by 20
Mapping the landscape of cerebral amyloid angiopathy research: an informetric analysis perspective
Charidimou, A., Fox, Z. V., Werring, D. J., & Song, M. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310690 · Cited by 20
Pallebage‐Gamarallage, M. M., Takechi, R., Lam, V., Elahy, M., & Mamo, J. C. L. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1115820 · Cited by 20
Ii, Y., Ishikawa, H., Matsuyama, H., Shindo, A., Matsuura, K., Yoshimaru, K., Satoh, M., Taniguchi, A., Matsuda, K., Umino, M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200992 · Cited by 20
Characterization of Japanese-American men with a single neocortical AD lesion type
Petrovitch, H., Ross, G. W., He, Q., Uyehara‐Lock, J. H., Markesbery, W. R., Davis, D. G., Nelson, J. R., Masaki, K., Launer, L. J., & White, L. R. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.026 · Cited by 19
Cerebral amyloid angiopathy-related hemorrhage in a middle-aged patient with Down's syndrome
Naito, K., Sekijima, Y., & Ikeda, S. (2008) · Amyloid · doi:10.1080/13506120802524981 · Cited by 19
Reuck, J. D., Auger, F., Durieux, N., Deramecourt, V., Cordonnier, C., Pasquier, F., Maurage, C., Leys, D., & Bordet, R. (2015) · Aging and Disease · doi:10.14336/ad.2015.0429 · Cited by 19
Imaging of Cerebral Amyloid Angiopathy with Bivalent 99mTc-Hydroxamamide Complexes
Iikuni, S., Ono, M., Watanabe, H., Matsumura, K., Yoshimura, M., Kimura, H., Ishibashi‐Ueda, H., Okamoto, Y., Ihara, M., & Saji, H. (2016) · Scientific Reports · doi:10.1038/srep25990 · Cited by 19
Reuck, J. D. (2019) · Neurology Research International · doi:10.1155/2019/7247325 · Cited by 20
Bürger, S., Yafai, Y., Bigl, M., Wiedemann, P., & Schliebs, R. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.07.231 · Cited by 20
Richardson, T. E., Walker, J. M., Farrell, K. W., Oliveira, T. G., White, C. L., & Crary, J. F. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02943-x · Cited by 25
Bonaterra‐Pastra, A., de Retana, S. F., Rivas-Urbina, A., Puig, N., Benı́tez, S., Pancorbo, O., Rodríguez‐Luna, D., Pujadas, F., Freijo, M. D. M., Tur, S., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9010072 · Cited by 21
A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease
Chen, H., Chen, F., Jiang, Y., Zhang, L., Hu, G., Sun, F., Zhang, M., Ji, Y., Chen, Y., Che, G., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.881239 · Cited by 19
Liu, X., Zhang, G., Pan, W. D., Hao, L., Zhong, L. X., Zhong, K., Liu, C., Liu, P., Feng, Q., Wang, S., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.995099 · Cited by 18
Cerebral Amyloid Angiopathy: An Undeniable Small Vessel Disease
Wang, L., Liu, Q., Yue, D., Liu, J., & Fu, Y. (2024) · Journal of Stroke · doi:10.5853/jos.2023.01942 · Cited by 20
Cerebrovascular Disease — Practical Issues in Surgical and Autopsy Pathology
Vinters, H. V. (2001) · Current topics in pathology · doi:10.1007/978-3-642-59554-7_2 · Cited by 18
Daffertshofer, M. (2002) · Springer eBooks · doi:10.1007/978-3-642-56225-9_68 · Cited by 18
Menéndez‐González, M., García‐García, J., Calleja, S., Rojo, J. A. P., & Ribacoba, R. (2009) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2009.00438.x · Cited by 18
Ventura‐Antunes, L., Nackenoff, A. G., Romero‐Fernandez, W., Wang, Y., Bosworth, A. M., Prusky, A., Wang, E., Carvajal‐Tapia, C., Shostak, A., Harmsen, H. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70254 · Cited by 20
Docosahexaenoic acid inhibits ischemic stroke to reduce vascular dementia and Alzheimer’s disease
Yamagata, K. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106733 · Cited by 17
Clinical-pathologic correlations in vascular cognitive impairment and dementia
Flanagan, M. E., Larson, E. B., Latimer, C. S., Cholerton, B., Crane, P. K., Montine, K. S., White, L. R., Keene, C. D., & Montine, T. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.019 · Cited by 17
Desmond, D. W. (2004) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2004.04.009 · Cited by 17
Skaaraas, G. H. E. S., Melbye, C., Puchades, M. A., Leung, D. S. Y., Jacobsen, Ø., Rao, S. B., Ottersen, O. P., Leergaard, T. B., & Torp, R. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210571 · Cited by 16
Kelly, L., Sharp, M. M., Thomas, I., Brown, C., Schrag, M., Antunes, L. V., Solopova, E., Martínez‐González, J., Rodrı́guez, C., & Carare, R. O. (2023) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2023.100171 · Cited by 14
Buciuc, M., Whitwell, J. L., Baker, M., Rademakers, R., Dickson, D. W., & Josephs, K. A. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12727 · Cited by 16
Dissociation of ERK and Akt signaling in endothelial cell angiogenic responses to β-amyloid
Magrané, J., Christensen, R. A., Rosen, K. M., Veereshwarayya, V., & Querfurth, H. W. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.12.009 · Cited by 16
Smooth muscle cells and the pathogenesis of cerebral microvascular disease (“angiomyopathies”)
Auerbach, I. D., Sung, S. H., Wang, Z., & Vinters, H. V. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00013-3 · Cited by 16
Cerebral Amyloid Angiopathy and Downstream Alzheimer Disease Plasma Biomarkers
Kang, S. H., Lee, E. H., Kim, Y. J., Jang, H., Shin, D., Zetterberg, H., Blennow, K., González‐Ortiz, F., Ashton, N. J., Yun, J., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.8842 · Cited by 16
A Review of APOE Genotype-Dependent Autophagic Flux Regulation in Alzheimer’s Disease
Chen, H., Chen, F., Zhang, M., Chen, Y., Cui, L., & Liang, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210602 · Cited by 15
Investigating the Interplay between Cardiovascular and Neurodegenerative Disease
Cousineau, J., Dawe, A. M., & Alpaugh, M. (2024) · Biology · doi:10.3390/biology13100764 · Cited by 15
Wardlaw, J. M. (2011) · Cerebrovascular Diseases · doi:10.1159/000326846 · Cited by 14
Gao, Y., Wei, S., Gao, F., Gao, L., Dang, L., Shang, S., Chen, C., Huo, K., Wang, J., Wang, J., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.615838 · Cited by 15
Doden, T., Sato, H., Sasahara, E., Murata, T., Yako, T., Kitazawa, K., Higuchi, K., Kobayashi, S., & Hashimoto, T. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2016.03.041 · Cited by 14
Lin, C., Arishima, H., Kikuta, K.-I., Naiki, H., Kitai, R., Kodera, T., Matsuda, K., Hashimoto, N., Isozaki, M., Tsunetoshi, K., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8740-z · Cited by 14
Development of a PET radioligand selective for cerebral amyloid angiopathy
Abrahamson, E. E., Stehouwer, J. S., Vazquez, A. L., Huang, G., Mason, N. S., Lopresti, B. J., Klunk, W. E., Mathis, C. A., & Ikonomović, M. D. (2020) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2020.05.001 · Cited by 13
Apolipoprotein E genotype and in vivo amyloid burden in middle-aged Hispanics
Palta, P., Rippon, B., Reitz, C., He, H., Sherwood, G., Ceballos, F., Teresi, J. A., Razlighi, Q. R., Moreno, H., Brickman, A. M., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010707 · Cited by 14
Tataryn, N. M., Singh, V., Dyke, J. P., Berk-Rauch, H., Clausen, D. M., Aronowitz, E., Norris, E. H., Strickland, S., & Ahn, H. J. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.07.015 · Cited by 15
Stanisavljevic, A., Schrader, J. M., Zhu, X. A., Mattar, J. M., Hanks, A. N., Xu, F., Majchrzak, M., Robinson, J. K., & Nostrand, W. E. V. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.811371 · Cited by 14
Supasitthumrong, T., Tunvirachaisakul, C., Aniwattanapong, D., Tangwongchai, S., Chuchuen, P., Tawankanjanachot, I., Snabboon, T., Hemrungrojn, S., Carvalho, A. F., & Maes, M. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190114 · Cited by 13
Hayes, C. A., Young, C. B., Ruiz, C. A., Reeves, A. N., Odden, M. C., Nirschl, J., Crane, P. K., Poston, K. L., Mormino, E. C., & Younes, K. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70059 · Cited by 16
Temporal Quantitative Profiling of Newly Synthesized Proteins during Aβ Accumulation
Ma, Y., McClatchy, D. B., Martínez‐Bartolomé, S., Bamberger, C., & Yates, J. R. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00645 · Cited by 10
[18F]FDG PET may differentiate cerebral amyloid angiopathy from Alzheimer’s disease
Bergeret, S., Queneau, M., Rodallec, M. H., Curis, E., Dumurgier, J., Hugon, J., Paquet, C., Farid, K., & Baron, J. (2021) · European Journal of Neurology · doi:10.1111/ene.14743 · Cited by 13
Reuck, J. D., Auger, F., Durieux, N., Cordonnier, C., Deramecourt, V., Pasquier, F., Maurage, C., Leys, D., & Bordet, R. (2016) · European Stroke Journal · doi:10.1177/2396987316650780 · Cited by 13
Hereditary and sporadic beta-amyloidoses
Fede, G. D. (2013) · Frontiers in bioscience · doi:10.2741/4173 · Cited by 13
Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort
Costa, A. S., Pinho, J., Kučikienė, D., Reich, A., Schulz, J. B., & Reetz, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201218 · Cited by 13
Alber, J., Arthur, E., Goldfarb, D., Drake, J., Boxerman, J. L., Silver, B., Ott, B. R., Johnson, L. N., & Snyder, P. J. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117383 · Cited by 13
Chapter 38 Intracerebral hemorrhage
Viswanathan, A., & Greenberg, S. M. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)93038-4 · Cited by 13
Greenberg, S. M. (2004) · Elsevier eBooks · doi:10.1016/b0-44-306600-0/50039-0 · Cited by 13
A 50-Year-Old Man With Acute-Onset Generalized Seizure
Mikolaenko, I., Mikolaenko, I., Conner, M., & Jinnah, H. A. (2006) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2006-130-e5-aymwag · Cited by 13
Kimura, A., Takemura, M., Saito, K., Yoshikura, N., Hayashi, Y., Harada, N., Nishida, H., Nakajima, H., & Inuzuka, T. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8362-2 · Cited by 13
Primary Progressive Aphasia Lacking Core Features of Nonfluent and Semantic Variants
Hiroyuki, W., Duffy, J. R., Clark, H. M., Machulda, M. M., Graff‐Radford, J., Pham, N. T. T., Dickson, D. W., Lowe, V. J., Whitwell, J. L., & Josephs, K. A. (2024) · Neurology · doi:10.1212/wnl.0000000000209924 · Cited by 12
İş, Ö., Min, Y., Wang, X., Oatman, S. R., Daniel, A. A., & Ertekin‐Taner, N. (2024) · Glia · doi:10.1002/glia.24652 · Cited by 13
Zerebrale Amyloidangiopathie und Demenz
Berlit, P., Keyvani, K., Krämer, M., & Weber, R. (2015) · Der Nervenarzt · doi:10.1007/s00115-015-4407-5 · Cited by 12
Tanskanen, M., Kalaria, R. N., Notkola, I.-L., Mäkelä, M. J., Polvikoski, T. M., Myllykangas, L., Sulkava, R. O., Kalimo, H., Paetau, A. E., Scheltens, P., et al. (2013) · Current Alzheimer Research · doi:10.2174/15672050113106660177 · Cited by 12
Modulators of Amyloid β-Protein (Aβ) Self-Assembly
Rahimi, F., Li, H. J., Sinha, S., & Bitan, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00006-x · Cited by 12
Reuck, J. L. D., Auger, F., Durieux, N., Cordonnier, C., Deramecourt, V., Pasquier, F., Maurage, C., Leys, D., & Bordet, R. (2016) · European Neurology · doi:10.1159/000447297 · Cited by 12
VEGF mimic peptides: Potential applications in central nervous system therapeutics
D’Andrea, L. D., Rosa, L. D., Vigliotti, C., & Cataldi, M. (2016) · European Journal of Molecular & Clinical Medicine · doi:10.1016/j.nhtm.2016.12.002 · Cited by 12
Metadata
- Authors
- Ellis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A.
- Affiliations
- University of California San Diego (US)
- Emory University (US)
- Washington University in St. Louis (US)
- University of Washington (US)
- Duke University (US)
- Venue
- Neurology
- Published
- 1996-06
- Volume
- 46
- Issue
- 6
- Pages
- 1592-1596
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2020068741
- Cited by
- 561
- References
- 26
- Citations by year
- 2026: 5 · 2025: 26 · 2024: 18 · 2023: 10 · 2022: 20 · 2021: 38 · 2020: 32 · 2019: 23 · 2018: 17 · 2017: 26 · 2016: 27 · 2015: 30 · 2014: 20 · 2013: 23 · 2012: 17
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Chinese Academy of Agricultural Sciences
- National Institute on Aging (AG06790, AG05131, P50AG005131, U01AG006790)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- cerebral amyloid angiopathy, Alzheimer's disease, intracerebral hemorrhage, ischemic lesions, cerebral arteriosclerosis, atherosclerosis, vascular pathology
- MeSH terms
- Aged, Alzheimer Disease, Arteriosclerosis, Brain, Cerebral Hemorrhage, Brain Ischemia, Female, Humans, Hypertension, Male, Middle Aged, Prospective Studies, United States, Comorbidity, Cerebral Amyloid Angiopathy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review